Posaconazole-D4
Cat. No.：YN250704
CAS No. ：1133712-26-1
| 产品名称: | Posaconazole-D4 |
| CAS No.: | 1133712-26-1 |
| Chemical Name: | 2,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol-d4; Noxafil-d4; Sch 56592-d4; |
| Synonyms: | SCH 56592-D4 |
| 分子量: | 704.80 |
| 分子式: | C₃₇H₃₈D₄F₂N₈O₄ |
| SMILES: | FC1=CC=C([C@@]2(CN3C=NC=N3)C[C@H](COC4=CC=C(N5CCN(C6=C([2H])C([2H])=C(N7C=NN([C@@H](CC)[C@H](C)O)C7=O)C([2H])=C6[2H])CC5)C=C4)CO2)C(F)=C1 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Posaconazole-D4 是Posaconazole的氘化标记形式。Posaconazole是一种广谱的，二代三唑类物质，具有抗真菌作用。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Cacciapuoti, A., et al.: Antimicrob. Agents Chemother., 44, 2017 (2000), Herbrecht, R., et al.: Int. J. Clin. Pract., 58, 612 (2004), Panackal, A., et al.: J. Clin. Microbiol., 44, 1740
